← Study Library
Review · 2025
Preclinicalcounts toward this tierRegeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing
McGuire FP, Martinez R, Lenz A, Skinner L, Cushman DM · Current Reviews in Musculoskeletal Medicine
Preclinicalcounts toward this tier
Identifies VEGFR2 and the Akt–eNOS axis as the load-bearing mechanisms, with ERK1/2 signalling and effects concentrated in poorly vascularised tissue such as tendon and the myotendinous junction; counts exactly three human pilot studies — intra-articular knee pain, interstitial cystitis, and intravenous safety — none of them controlled, and concludes BPC-157 should be treated as investigational.
- Population
- Scoping review of BPC-157 mechanisms, musculoskeletal evidence and safety
- Intervention
- n/a
- Comparator
- n/a
- Limitations
- Narrative scoping design without formal quality appraisal; independent of the originating network, but its preclinical inputs are not.
Cited by
1 entry references this study
- BPC-157PRECL.
Peptides → Preclinical & experimental